-
1
-
-
0017132731
-
Hydroxyldaunomycin (adriamycin) combination chemotheraphy in malignant lymphoma
-
McKelvey EM, Gottlieb JA, Wilson HF. et al. Hydroxyldaunomycin (adriamycin) combination chemotheraphy in malignant lymphoma. Cancer 1476; 38: 1484-93.
-
(1476)
Cancer
, vol.38
, pp. 1484-1493
-
-
McKelvey, E.M.1
Gottlieb, J.A.2
Wilson, H.F.3
-
2
-
-
0025105137
-
The m-BACOD combination chemotherapy regimen in large-cell lymphoma: Analysis of the completed trial and comparison with the m-BACOD regimen
-
Shipp MA, Young B, Harrington DP et al. The m-BACOD combination chemotherapy regimen in large-cell lymphoma: Analysis of the completed trial and comparison with the m-BACOD regimen. J Clin Oncol 1990; 8: 84-93.
-
(1990)
J Clin Oncol
, vol.8
, pp. 84-93
-
-
Shipp, M.A.1
Young, B.2
Harrington, D.P.3
-
3
-
-
0023840154
-
COPBLAM III infusional combination chemotherapy for diffuse large-cell lymphoma
-
Boyd DB, Coleman M, Papish SW et al. COPBLAM III infusional combination chemotherapy for diffuse large-cell lymphoma. J Clin Oncol 1988; 6: 425-33.
-
(1988)
J Clin Oncol
, vol.6
, pp. 425-433
-
-
Boyd, D.B.1
Coleman, M.2
Papish, S.W.3
-
4
-
-
0025958183
-
Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: Results of a prospective randomized trial
-
Longo D, DeVita VT, Duffey P et al. Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: Results of a prospective randomized trial. J Clin Oncol 1991; 9: 25-38.
-
(1991)
J Clin Oncol
, vol.9
, pp. 25-38
-
-
Longo, D.1
DeVita, V.T.2
Duffey, P.3
-
5
-
-
0023987023
-
MACOP-B chemotherapy for malignant lymphomas and related conditions: 1987 update and additional observations
-
Connors SM, Klimo P. MACOP-B chemotherapy for malignant lymphomas and related conditions: 1987 update and additional observations. Semin Hematol 1988; 25: 41-6.
-
(1988)
Semin Hematol
, vol.25
, pp. 41-46
-
-
Connors, S.M.1
Klimo, P.2
-
6
-
-
0025790543
-
Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma
-
Sweetenham JW, Mead GM, Whitehouse JMA. Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma. J Clin Oncol 1991; 9: 2202-9.
-
(1991)
J Clin Oncol
, vol.9
, pp. 2202-2209
-
-
Sweetenham, J.W.1
Mead, G.M.2
Whitehouse, J.M.A.3
-
7
-
-
0027394689
-
Comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate or high-grade non-Hodgkin's lymphomas
-
Fisher RI, Gayner ER, Dahlberg M et al. Comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate or high-grade non-Hodgkin's lymphomas. N Engl J Med 1993; 328: 1002-6.
-
(1993)
N Engl J Med
, vol.328
, pp. 1002-1006
-
-
Fisher, R.I.1
Gayner, E.R.2
Dahlberg, M.3
-
8
-
-
0027468191
-
A comparative study of CHOP versus MEVP (mitoxantrone, etoposide, vindesine, prednisolone) therapy for intermediate-grade and high-grade non-Hodgkin's lymphoma: A prospective randomized study
-
Takagi T, Sampi K, Sawada U et al. A comparative study of CHOP versus MEVP (mitoxantrone, etoposide, vindesine, prednisolone) therapy for intermediate-grade and high-grade non-Hodgkin's lymphoma: A prospective randomized study, Int J Hematol 1993; 57: 67-71.
-
(1993)
Int J Hematol
, vol.57
, pp. 67-71
-
-
Takagi, T.1
Sampi, K.2
Sawada, U.3
-
9
-
-
0028293076
-
Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma
-
Cooper IA. Wolf MM, Fox RM et al for the New Zealand Lymphoma Group. Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. J Clin Oncol 1994; 12: 769-78.
-
(1994)
J Clin Oncol
, vol.12
, pp. 769-778
-
-
Cooper, I.A.1
Wolf, M.M.2
Fox, R.M.3
-
10
-
-
9344248372
-
A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: A British National Lymphoma Investigation report
-
Linch DC, Vaughan Hudson B, Hancock BW et al. A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: A British National Lymphoma Investigation report. Br J Cancer 1996; 74: 318-22.
-
(1996)
Br J Cancer
, vol.74
, pp. 318-322
-
-
Linch, D.C.1
Vaughan Hudson, B.2
Hancock, B.W.3
-
11
-
-
0025836032
-
Lymphoma in the elderly
-
Fiorentino MV. Lymphoma in the elderly. Leukemia 1991; 5: 79 -85.
-
(1991)
Leukemia
, vol.5
, pp. 79-85
-
-
Fiorentino, M.V.1
-
12
-
-
0021887662
-
VP-16-213 in the treatment of stage III and IV diffuse large-cell lymphoma
-
Jacobs P, King HS, Dent DM, Hayes M, VP-16-213 in the treatment of stage III and IV diffuse large-cell lymphoma. Cancer 1985; 56: 1006-13.
-
(1985)
Cancer
, vol.56
, pp. 1006-1013
-
-
Jacobs, P.1
King, H.S.2
Dent, D.M.3
Hayes, M.4
-
13
-
-
0027520881
-
Chronic administration of etoposide in the treatment of non-Hodgkin's lymphoma
-
Hainsworth JD, Chronic administration of etoposide in the treatment of non-Hodgkin's lymphoma. Leuk Lymph 1993; 10 (Suppl): 65-72.
-
(1993)
Leuk Lymph
, vol.10
, Issue.SUPPL.
, pp. 65-72
-
-
Hainsworth, J.D.1
-
14
-
-
0019254230
-
VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine and prednisone in the treatment of non-Hodgkin's lymphomas
-
Hansen MM, Blomfield CD, Jörgensen J et al. VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine and prednisone in the treatment of non-Hodgkin's lymphomas. Cancer Treat Rep 1980; 64: 1135-7.
-
(1980)
Cancer Treat Rep
, vol.64
, pp. 1135-1137
-
-
Hansen, M.M.1
Blomfield, C.D.2
Jörgensen, J.3
-
15
-
-
0027182362
-
EPOCH chemotherapy: Toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma
-
Wilson WH, Bryant G, Bates et al. EPOCH chemotherapy: Toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma. J Clin Oncol 1993; 11: 1573-82.
-
(1993)
J Clin Oncol
, vol.11
, pp. 1573-1582
-
-
Wilson, W.H.1
Bryant, G.2
Bates3
-
16
-
-
0028005329
-
Randomised comparison of CHOEP versus alternating hCHOP. IVEP for high-grade non-Hodgkin's lymphomas: Treatment results and prognostic factor analysis in a multi-centre trial
-
Koppler H, Pfluger KH, Eschenbach I et al. Randomised comparison of CHOEP versus alternating hCHOP. IVEP for high-grade non-Hodgkin's lymphomas: Treatment results and prognostic factor analysis in a multi-centre trial. Ann Oncol 1994: 5: 49-55.
-
(1994)
Ann Oncol
, vol.5
, pp. 49-55
-
-
Koppler, H.1
Pfluger, K.H.2
Eschenbach, I.3
-
17
-
-
0028938612
-
Infusional chemotherapy (EPOCH) in patients with refractory or relapsed lymphoma
-
Carrion JR, Garcia Arroyo FR, Salinas P, Infusional chemotherapy (EPOCH) in patients with refractory or relapsed lymphoma. Am J Clin Oncol 1995; 18: 44-6.
-
(1995)
Am J Clin Oncol
, vol.18
, pp. 44-46
-
-
Carrion, J.R.1
Garcia Arroyo, F.R.2
Salinas, P.3
-
18
-
-
0029587694
-
Vincristine, doxorubicin, cyclophosphamide, prednisone and etoposide (VACPE) in high-grade non-Hodgkin's lymphoma-a multicenter phase II study
-
Bergmann L, Karakas T, Lautenschläger G et al. Vincristine, doxorubicin, cyclophosphamide, prednisone and etoposide (VACPE) in high-grade non-Hodgkin's lymphoma-a multicenter phase II study. Ann Oncol 1995; 6: 1019-24.
-
(1995)
Ann Oncol
, vol.6
, pp. 1019-1024
-
-
Bergmann, L.1
Karakas, T.2
Lautenschläger, G.3
-
20
-
-
0023930572
-
Updated Kiel Classification for lymphoma
-
Stansfeld A, Diebold J, Kapanci Y et al. Updated Kiel Classification for lymphoma. Lancet 1988; i: 292-3.
-
(1988)
Lancet
, vol.1
, pp. 292-293
-
-
Stansfeld, A.1
Diebold, J.2
Kapanci, Y.3
-
21
-
-
0015150080
-
Report of the committee on Hodgkin's disease staging classification
-
Carbone PP, Kaplan HS, Musshoff K et al. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971; 31: 1860-1.
-
(1971)
Cancer Res
, vol.31
, pp. 1860-1861
-
-
Carbone, P.P.1
Kaplan, H.S.2
Musshoff, K.3
-
22
-
-
0023143097
-
Results of MIME salvage regimen for recurrent or refractory lymphoma
-
Cabanillas F, Hagemeister FB, McLaughlin P et al. Results of MIME salvage regimen for recurrent or refractory lymphoma. J Clin Oncol 1987; 5: 407-12.
-
(1987)
J Clin Oncol
, vol.5
, pp. 407-412
-
-
Cabanillas, F.1
Hagemeister, F.B.2
McLaughlin, P.3
-
23
-
-
33845382806
-
Nonparametric estimation from incomplete observations
-
Kaplan EM, Meier P. Nonparametric estimation from incomplete observations, J Am Stat Assoc 1958; 53: 457-81.
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.M.1
Meier, P.2
-
24
-
-
7844242228
-
Design and analysis of randomised clinical trials requiring prolonged observations of each patient
-
Peto R, Pike MC, Armilage P et al. Design and analysis of randomised clinical trials requiring prolonged observations of each patient. Br J Cancer 1971; 38: 1484-93.
-
(1971)
Br J Cancer
, vol.38
, pp. 1484-1493
-
-
Peto, R.1
Pike, M.C.2
Armilage, P.3
-
25
-
-
0028012062
-
Prognostic factors in aggressive non-Hodgkin's lymphoma who has high-risk disease
-
Shipp MA, Prognostic factors in aggressive non-Hodgkin's lymphoma who has high-risk disease. Blood 1994; 83: 1165-73.
-
(1994)
Blood
, vol.83
, pp. 1165-1173
-
-
Shipp, M.A.1
-
26
-
-
0025970652
-
The evolving role of etoposide in the management of lymphomas and Hodgkin's disease
-
O'Reilly SE, Klimo P, Connors JM. The evolving role of etoposide in the management of lymphomas and Hodgkin's disease. Cancer 1991; 67: 271-80.
-
(1991)
Cancer
, vol.67
, pp. 271-280
-
-
O'Reilly, S.E.1
Klimo, P.2
Connors, J.M.3
-
27
-
-
0022504479
-
Investigation of the addition potential of tenoposide and vincristine in non-Hodgkin lymphomas
-
Australian and New Zealand lymphoma group. Investigation of the addition potential of tenoposide and vincristine in non-Hodgkin lymphomas, Cancer Treat Rep 1986: 70: 985-90.
-
(1986)
Cancer Treat Rep
, vol.70
, pp. 985-990
-
-
-
28
-
-
0030964191
-
Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma
-
Zinzani PL, Pavone E, Storti S et al. Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma. Blood 1997; 89: 3974-9.
-
(1997)
Blood
, vol.89
, pp. 3974-3979
-
-
Zinzani, P.L.1
Pavone, E.2
Storti, S.3
-
29
-
-
0026667676
-
Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: A randomized controlled trial
-
Pettengell R, Gurney H, Radford JA et al. Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: A randomized controlled trial. Blood 1992; 80: 1430-6.
-
(1992)
Blood
, vol.80
, pp. 1430-1436
-
-
Pettengell, R.1
Gurney, H.2
Radford, J.A.3
-
30
-
-
0027517297
-
Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyle-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas
-
Gerhartz HH, Engelhard M, Meusers P et al. Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyle-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas. Blood 1993; 82: 2329-39.
-
(1993)
Blood
, vol.82
, pp. 2329-2339
-
-
Gerhartz, H.H.1
Engelhard, M.2
Meusers, P.3
|